ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12496 recruiting trials
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
👨⚕️ Won Sik Ham, Department of Urology and Urological Science Institute, Yonsei University College of Medicine📍 3 sites📅 Started Jul 2023View details ↗
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma
👨⚕️ Lei Zhang, PhD, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University📍 1 site📅 Started Jul 2023View details ↗
Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels
Tools to Identify People At Risk or Already Infected with HIV and HCV
🏥 Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal📍 1 site📅 Started Jul 2023View details ↗
Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma
👨⚕️ Liu Guohua, Affiliated Hospital of Guangdong Medical University📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT07373288 ↗
HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis
RecruitingNCT05965115 ↗
The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
RecruitingNCT05833594 ↗
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
RecruitingNCT05906316 ↗
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
👨⚕️ Jakko van Ingen, MSc, PhD, Radboud University Medical Center📍 11 sites📅 Started Jul 2023View details ↗
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
👨⚕️ Moh'd Abu Hilal, MD, PhD, Fondazione Poliambulanza Instituto Ospedaliero📍 1 site📅 Started Jul 2023View details ↗
PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC
👨⚕️ Yu Weiwei, Department of Radiation Oncology, Affiliated Hospital of Nantong University📍 1 site📅 Started Jul 2023View details ↗
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
👨⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT05702502 ↗
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
RecruitingNCT06894290 ↗
International Cardiac Amyloidosis Registry
👨⚕️ Nina Ajmone Marsan, MD, PhD, Leiden University Medical Center📍 6 sites📅 Started Jun 2023View details ↗
RecruitingNCT06194669 ↗
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →